New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2013
09:23 EDTZNGA, LNCO, LINE, S, NLSN, HDSN, NVAX, FMS, DVA, ACHN, MSFT, BRYOn The Fly: Pre-market Movers
HIGHER: Zynga (ZNGA), up 12% after confirming it hired former Microsoft (MSFT) executive Don Mattrick as CEO... Nielsen Holdings (NLSN), up 4.2% after being selected to replace Sprint (S) in the S&P 500 after the close of trading on July 8... Novavax (NVAX), up 3.8% after announcing top-line results from Phase 1 trial of RSV vaccine candidate. LOWER: Hudson Technologies (HDSN), down 30% after warning on earnings, downgrade at Roth Capital... Achillion Pharmaceuticals (ACHN), down 21% after FDA placed clinical hold on development of the company's hepatitis C drug sovaprevir... LINN Energy (LINE), down 11% after disclosing informal SEC inquiry, downgrades at JPMorgan and Raymond James. LinnCo (LNCO) down 10% and Berry Petroleum (BRY) down 6% on news as well... DaVita (DVA), down 6.5%, Fresenius Medical (FMS), down 8.7%, after CMS proposed rules that would lower Medicare dialysis spending... Constellation Brands (STZ), down 2% after Q1 adjusted EPS miss expectations.
News For ZNGA;MSFT;ACHN;DVA;FMS;NVAX;HDSN;NLSN;S;LINE;LNCO;BRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 8, 2014
15:49 EDTACHNAchillion, Gilead rise after late breaking abstract for AASLD posted
Shares of Achillion (ACHN) are higher after the company announced this morning that four abstracts have been accepted for presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases. Among those four is a late breaker poster presentation providing updated results, including SVR12, from an ongoing Phase 2 proxy study evaluating Achillion's second-generation NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for eight weeks of treatment in patients with treatment-na´ve genotype 1 chronic hepatitis C virus infection. Sofosbuvir is sold under the brand name Sovaldi by Gilead Sciences (GILD). In a note to investors, FBR Capital noted that the "surprise" late-breaking poster for the meeting showed a 100% cure rate for the combination therapy. In late afternoon trading, Achillion shares are up 10% to $10.74 while Gilead is up 4.3% to $108.78.
11:10 EDTLNCO, LINEOptions with increasing implied volatility
Subscribe for More Information
10:48 EDTZNGAGlu drops despite Benchmark optimism about Kardashian game
Research firm Benchmark Co. upgraded digital video game maker Glu Mobile (GLUU) to Buy from Hold, based on optimism about the company's upcoming third quarter earnings report. WHAT'S NEW: Glu may report higher than expected third quarter sales and earnings before interest taxes depreciation and amortization on October 29, Benchmark analyst Mike Hickey wrote in a note to investors today. The company may also raise its fourth quarter guidance, Hickey believes. Glu's results are being lifted by the success of the company's "Kim Kardashian: Hollywood" game, the analyst believes. He has a $5.90 price target on the name. WHAT'S NOTABLE: Taking the opposite view on Glu Mobile in an article yesterday was a short-selling blog, TheStreetSweeper. The blog said it "wouldn't be surprised" if the company cut its Q4 guidance, as Kim Kardashian and other Glu games "are fading fast." Company insiders are "selling huge chinks" of the company's shares, added the blog. Northland Capital analyst Darren Aftahi yesterday countered by accusing TheStreetSweeper of "acting as a megaphone" for shorts in the name, trying to drive down the stock in a weak market, and producing an article that is "full of conjecture." The analyst said he thinks the company could beat Q3 revenue expectations by a large amount, potentially producing a "massive short squeeze." OTHERS TO WATCH: Other digital video game makers include Zynga (ZNGA) and King Digital (KING). PRICE ACTION: In early trading, Glu dropped 4% to $4.56.
07:09 EDTSSprint to shut down WiMAX network around November 6, 2015, FierceWireless says
Subscribe for More Information
06:13 EDTMSFTNon-Apple notebook, tablet demand to be weak till 2Q15, DigiTimes reports
Demand for non-Apple (AAPL) notebooks and tablets may remain weak until the second quarter of 2015, reports DigiTimes. Citing Taiwan makers, the pressure due to booming sales from Apple products may decrease sales until Microsoft (MSFT) launches Windows 10 next year. Demand for Samsung (SSNLF), Sony (SNE) , And HTC smartphones have also dropped worldwide recently. Reference Link
October 7, 2014
12:50 EDTMSFTSamsung aiming for arbitration versus Microsoft, Bloomberg says
Subscribe for More Information
12:45 EDTMSFTMicrosoft near deal to buy text analysis start-up for about $200M, WSJ says
Subscribe for More Information
12:45 EDTMSFTMicrosoft to hold cloud event on October 20
Subscribe for More Information
10:56 EDTACHNOptions with increasing implied volatility
Subscribe for More Information
10:52 EDTMSFTNokia suspends handset production at Chennai facility, Reuters reports
Subscribe for More Information
10:02 EDTNVAXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:36 EDTACHNActive equity options trading on open
Subscribe for More Information
07:48 EDTMSFTU.S. Chamber of Commerce to hold a discussion
Subscribe for More Information
07:05 EDTNVAXNovavax initiated with an Overweight at JPMorgan
JPMorgan says it is impressed by the potential of Novavax's proprietary recombinant nanoparticle vaccine technology. The firm started shares with an Overweight rating and $7 price target.
07:00 EDTMSFTReport says 100K Xbox Ones sold throughout China, Kotaku says
A report from Chinese video games news website 17173 said that Shanghai Media Group vice-president Zhang Dazhong accidentally noted that over 100K Microsoft Xbox One consoles sold throughout China during the first week they were launched, according to Kotaku, citing the report from 17173. Reference Link
05:52 EDTSStocks with implied volatility movement; S HIMX
Subscribe for More Information
October 6, 2014
11:09 EDTACHNOptions with increasing implied volatility
Subscribe for More Information
10:02 EDTSKajeet collaborates with Novatel Wireless
Subscribe for More Information
07:55 EDTNLSNRentrak price target raised to $84 from $72 at Brean Capital
Brean Capital raised its price target on Rentrak (RENT) to $84 from $72 citing positive momentum for TV Everywhere and lower risk in the stock given the company's operating leverage, strong cash flow, and potential for value expansion. The firm believes Rentrak can replace Nielson (NLSN) and reiterates its Buy rating on shares of Rentrak.
06:21 EDTMSFTMicrosoft 2015 solution may not help suppress Chromebook growth, DigiTimes says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use